Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks - Gabrilove, Janice L; Perez, Edith A; Tomita, Dianne K; Rossi, Greg; Cleeland, Charles S (Cancer, 2007)
Keywords: Adult; Aged; Aged, 80 and over; Anemia, Hypochromic - chemically induced; Anemia, Hypochromic - complications; Anemia, Hypochromic - drug therapy; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Cost of Illness; Darbepoetin alfa; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythropoietin - administration & dosage; Erythropoietin - analogs & derivatives; Erythropoietin - therapeutic use; Fatigue - etiology; Female; Hematinics - administration & dosage; Hematinics - therapeutic use; Humans; Male; Middle Aged; Surveys and Questionnaires; Treatment Outcome